Structure Therapeutics Inc. Sponsored ADR (GPCR)
(Delayed Data from NSDQ)
$34.20 USD
+0.44 (1.30%)
Updated May 31, 2024 04:00 PM ET
After-Market: $34.25 +0.05 (0.15%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.19 |
Last EPS Surprise | 9.52% |
ABR | 1.00 |
Earnings ESP
|
-3.70% |
---|---|
Current Year | -0.94 |
Next Year | -0.87 |
EPS (TTM) | -0.77 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 200.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 200.00M |
Low Estimate | NA | NA | NA | 200.00M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.24 | -0.94 | -0.87 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | -0.23 | -0.22 | -0.86 | -1.03 |
High Estimate | -0.20 | -0.22 | -0.84 | 0.35 |
Low Estimate | -0.24 | -0.25 | -1.10 | -1.49 |
Year ago EPS | -0.20 | -0.21 | -0.81 | -0.94 |
Year over Year Growth Est. | -15.00% | -14.29% | -16.05% | 7.45% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 3 | 1 |
Up Last 60 Days | 1 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 3 | 1 | 2 |
Down Last 60 Days | 1 | 2 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.24 | -0.94 | -0.87 |
7 Days Ago | -0.23 | -0.24 | -0.94 | -0.87 |
30 Days Ago | -0.21 | -0.22 | -0.98 | -0.68 |
60 Days Ago | -0.21 | -0.22 | -0.96 | -0.76 |
90 Days Ago | -0.31 | -0.36 | -1.00 | -0.72 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.24 | -0.90 | -1.28 |
Zacks Consensus Estimate | -0.23 | -0.24 | -0.94 | -0.87 |
Earnings ESP | -3.70% | 0.00% | 4.26% | -46.75% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.19 | -0.17 | -0.21 | -0.20 | NA |
Estimate | -0.21 | -0.21 | -0.22 | -0.19 | NA |
Difference | 0.02 | 0.04 | 0.01 | -0.01 | 0.02 |
Surprise | 9.52% | 19.05% | 4.55% | -5.26% | 6.97% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more